Sonya L Heltshe

7PUBLICATIONS
15CO-AUTHORS
MortalityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Fluid-structure interaction and aeroacousticsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 24, 2026
Risk factors for longitudinal estimated glomerular filtration rate decline in adults with cystic fibrosis.

Deepthi Nacharaju, Leila R Zelnick, Kathleen J Ramos

|Jun 25, 2024
Statistical approaches for the integration of external controls in a cystic fibrosis clinical trial: a simulation and an application.

Mark N Warden, Sonya L Heltshe, Noah Simon

|Oct 28, 2021
Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial.

David P Nichols, Pradeep K Singh, Arthur Baines

|Oct 12, 2019
Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.

J Kirk Harris, Brandie D Wagner, Edith T Zemanick

|Dec 25, 2018
CFTR Modulator Use Is Associated with Higher Hemoglobin Levels in Individuals with Cystic Fibrosis.

Alex H Gifford, Sonya L Heltshe, Christopher H Goss

|Apr 26, 2015
Short-term and long-term response to pulmonary exacerbation treatment in cystic fibrosis.

Sonya L Heltshe, Christopher H Goss, Valeria Thompson

Pageof 2

Frequent Collaborators

2 joint publications

Christopher H Goss

1 joint publications

Alex H Gifford

1 joint publications

J Kirk Harris

1 joint publications

Brandie D Wagner